Breaking Down Interparfums SA Financial Health: Key Insights for Investors

FR | Consumer Defensive | Household & Personal Products | EURONEXT

Interparfums SA (ITP.PA) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors tracking Interparfums SA should pay close attention to a string of concrete financial signals: Q1 2025 net sales reached $339 million (up 5% year-over-year from $324 million) while H1 2025 sales hit €446.9 million (a 6% increase), supported by brand momentum from Jimmy Choo, Coach and Lacoste and a gross margin improvement to 65.5% (up 60 bps); profitability shows resilience with a Q1 operating margin of 25.3% and net margin at 16.5%, H1 net income of €73.1 million (up 5%), and an effective tax rate easing to 25.5%-balanced by a conservative balance sheet featuring €57 million in cash net of borrowings, shareholders' equity near €700 million (66% of assets), a 0.21 debt-to-equity ratio and a strong free cash flow of €112.61 million in 2024 (up 185.8%); valuation signals are mixed-intrinsic value €23.16 vs market €24.94 (≈7.10% overvaluation), Peter Lynch fair value €39.82 (≈58.26% upside), DCF 10-year $29.67 (≈8.8% upside) with a P/E of 15.80x-while key risks (currency exposure, the discontinued Dunhill license affecting U.S. sales, inventory pressures and macro uncertainty) are offset by growth levers like the Coach license renewal to June 30, 2031, the Solférino proprietary line, and planned acquisitions (Off-White and Annick Goutal in 2026) that expand the high-end fragrance footprint and support the company's innovation and distribution strategies

Interparfums SA (ITP.PA) - Revenue Analysis

Interparfums SA reported mixed but broadly positive top-line trends into 2025. Net sales for Q1 2025 reached $339 million, up 5% versus $324 million in Q1 2024, driven primarily by strength in Europe and continued momentum from core licensed brands. The company reaffirmed full-year 2025 guidance of net sales of $1.51 billion, implying roughly a 4% increase year-over-year.
  • Q1 2025 net sales: $339 million (+5% vs Q1 2024 $324 million).
  • H1 2025 net sales: €446.9 million (+6% vs H1 2024 €422.6 million).
  • Full-year 2025 guidance: $1.51 billion net sales (reaffirmed, +4% expected).
Regional highlights and brand drivers:
  • Europe: sales increased ~7% year-over-year in Q1 2025, the strongest geographic contributor to growth.
  • United States: sales declined ~1% in Q1 2025, negatively impacted by the discontinued Dunhill license.
  • Key growth brands: Jimmy Choo, Coach, and Lacoste-these three brands remain primary contributors to volume and value growth.
Profitability and margin context:
  • Gross margin (H1 2025): 65.5%, up 60 basis points from 64.9% in H1 2024, reflecting mix improvements and pricing leverage.
  • Margin expansion supports operating leverage despite the U.S. license exit effect on sales.
Metric Period Amount Year-over-Year Change
Net Sales Q1 2025 $339 million +5% vs Q1 2024 ($324M)
Net Sales H1 2025 €446.9 million +6% vs H1 2024 (€422.6M)
Gross Margin H1 2025 65.5% +60 bps vs H1 2024 (64.9%)
Full-Year Guidance FY 2025 $1.51 billion ~+4% vs FY 2024 (reaffirmed)
Regional Performance Q1 2025 Europe: +7% / U.S.: -1% Europe outperformed; U.S. impacted by Dunhill license exit
For context on strategic positioning and long-term objectives, see Mission Statement, Vision, & Core Values (2026) of Interparfums SA.

Interparfums SA (ITP.PA) - Profitability Metrics

Interparfums SA's recent reported margins and profitability indicators for Q1 and H1 2025 show modest improvement quarter-on-quarter and mixed year-on-year movement, with net income growth and a slightly lower effective tax rate.

  • Q1 2025 operating margin: 25.3% (Q1 2024: 25.0%).
  • Q1 2025 net margin: 16.5% (Q1 2024: 16.0%).
  • H1 2025 operating margin: 23.2% (H1 2024: 21.9%).
  • H1 2025 net margin: 16.4% (H1 2024: 16.5%).
  • H1 2025 net income: €73.1 million (H1 2024: €69.6 million; +5%).
  • H1 2025 effective tax rate: 25.5% (H1 2024: 26.9%).
Metric Q1 2024 Q1 2025 H1 2024 H1 2025
Operating Margin 25.0% 25.3% 21.9% 23.2%
Net Margin 16.0% 16.5% 16.5% 16.4%
Net Income (€m) - - 69.6 73.1
Effective Tax Rate - - 26.9% 25.5%

Key implications for investors:

  • Operating margin expansion in both Q1 and H1 2025 signals better core profitability and/or cost control.
  • Net margin improvement in Q1 2025 supports stronger bottom-line conversion of revenues; H1 net margin shows stability despite a small percentage variance.
  • Net income growth of €3.5 million (+5%) in H1 2025 reinforces earnings momentum.
  • Lower effective tax rate in H1 2025 provides a modest tailwind to net earnings.

For further context on ownership, investor composition and strategic drivers that can affect these profitability trends see: Exploring Interparfums SA Investor Profile: Who's Buying and Why?

Interparfums SA (ITP.PA) - Debt vs. Equity Structure

Interparfums presents a capital structure characterized by a strong equity base and limited financial leverage as of December 31, 2024. Key headline figures highlight cash strength, a dominant equity position on the balance sheet, and conservative use of debt.
  • Cash net of borrowings and financial liabilities: €57.0 million (Dec 31, 2024)
  • Shareholders' equity: ~€700 million, representing 66% of total assets
  • Debt-to-equity ratio: 0.21
  • Equity ratio: 67.5%
Metric Value Comment
Cash net of borrowings €57.0m Positive net cash position after accounting for borrowings and financial liabilities
Shareholders' equity ~€700.0m Represents ~66% of total assets - dominant funding source
Debt-to-equity ratio 0.21 Low leverage; €0.21 of debt per €1 of equity
Equity ratio 67.5% High proportion of assets financed by equity
A few implications for investors:
  • Stability: High equity ratio (67.5%) cushions asset volatility and supports resilience during downturns.
  • Financial flexibility: Net cash of €57m and low leverage leave room to fund M&A, brand investments, or shareholder returns without relying heavily on external debt.
  • Risk profile: Debt-to-equity of 0.21 indicates conservative financial risk, lowering solvency concerns and interest burden sensitivity.
For deeper context on ownership and investor activity, see: Exploring Interparfums SA Investor Profile: Who's Buying and Why?

Interparfums SA (ITP.PA) Liquidity and Solvency

Interparfums SA finished the year with a notably strong liquidity and solvency profile driven by robust cash generation and conservative balance sheet management. Key 2024 figures underline the company's ability to meet short-term obligations and maintain strategic flexibility.
  • Cash net of borrowings and financial liabilities: €57.0 million (as of Dec 31, 2024)
  • Free cash flow (2024): €112.61 million - a 185.8% increase vs. 2023
  • Operating cash flow to net income ratio: 0.83
  • Free cash flow to net income ratio: 0.67
  • Strong cash reserves supporting both operations and potential capital allocation
Metric 2024 2023 (for comparison) Comment
Cash net of borrowings & financial liabilities €57.0m - Net cash position provides immediate liquidity buffer
Free Cash Flow (FCF) €112.61m €39.27m (implied) 185.8% YoY increase signals improved cash conversion
Operating Cash Flow / Net Income 0.83 - Strong operational cash conversion
Free Cash Flow / Net Income 0.67 - Indicates healthy surplus after investments
  • High FCF and solid net cash offer solvency protection against cyclical risk and support shareholder returns or M&A optionality.
  • OCF-to-net-income near 1.0 demonstrates earnings quality and limited accrual distortion.
  • FCF-to-net-income of 0.67 indicates room for capex and dividends while preserving balance sheet strength.
Exploring Interparfums SA Investor Profile: Who's Buying and Why?

Interparfums SA (ITP.PA) - Valuation Analysis

Interparfums SA's valuation profile as of December 12, 2025 shows mixed signals across valuation methodologies, with market price slightly above an intrinsic estimate but well below a Peter Lynch fair-value calculation. Key headline figures:
  • Intrinsic value: €23.16 vs. market price €24.94 → 7.10% overvaluation.
  • Peter Lynch fair value: €39.82 → 58.26% upside from current market price.
  • DCF (10-year): $29.67 → ~8.8% upside vs. current market price.
  • DCF (5-year): $22.88 → ~16.1% downside vs. current market price.
  • P/E: 15.80x; Forward P/E: 15.64x.
  • Enterprise value: €2,178.03 million; Market capitalization: €2,088.23 million.
Metric Value Implied Change vs Market
Market Price (12/12/2025) €24.94 -
Intrinsic Value €23.16 -7.10% (overvaluation)
Peter Lynch Fair Value €39.82 +58.26% (upside)
DCF (10-yr) $29.67 +8.8% (upside)
DCF (5-yr) $22.88 -16.1% (downside)
P/E 15.80x -
Forward P/E 15.64x -
Enterprise Value (EV) €2,178.03 million -
Market Capitalization €2,088.23 million -
  • Valuation divergence: The Peter Lynch method produces a materially higher fair value than both intrinsic and DCF approaches, implying that growth expectations or earnings visibility under that heuristic are more optimistic.
  • DCF timeframe sensitivity: The 10-year DCF is modestly accretive relative to market price, while the 5-year DCF implies downside - highlighting sensitivity to forecast horizon and terminal assumptions.
  • Relative multiples: P/E and forward P/E in the mid-teens suggest a valuation consistent with mature-growth consumer-branded peers rather than high-growth luxury names.
  • Capital structure context: EV ~€2.178B vs. market cap ~€2.088B indicates modest net debt/lease adjustments embedded in enterprise value.
For context on Interparfums' strategic positioning and long-term objectives that underpin valuation assumptions, see Mission Statement, Vision, & Core Values (2026) of Interparfums SA.

Interparfums SA (ITP.PA) Risk Factors

Interparfums SA operates in a margin-sensitive, brand-driven consumer segment where currency moves, licensing dynamics and supply-chain frictions can materially affect near-term results and medium-term profitability. Key risk vectors investors should monitor include currency exposure, licensing disruptions (notably the Dunhill change in the U.S. in Q1 2025), demand volatility across geographies, inventory build-ups, brand/competitive pressure and regulatory shifts.
  • Currency exchange risk: the company reports a significant portion of sales in U.S. dollars while reporting in euros, creating translation and transaction exposure. Management commentary and sensitivity analyses indicate that a 5% adverse movement in EUR/USD historically alters operating profit by an amount in the low double-digit millions of euros.
  • Dunhill license discontinuation: the loss (or discontinuation) of the Dunhill license contributed to a measurable decline in U.S. sales in Q1 2025, with North American revenue down versus the prior-year quarter. This highlights concentration risk tied to contractual licensing arrangements.
  • Macroeconomic and demand risks: moderating consumer demand in key international markets (Europe, the Americas and parts of Asia) can pressure volumes, SKU rollouts and SKU profitability, especially for premium fragrance launches.
  • Supply chain and inventory risk: disruptions have led to elevated finished-goods inventories, tying up working capital and increasing obsolescence risk for seasonal/skewed SKUs.
  • Brand and competitive risk: Interparfums' economics depend on the performance of partner/licensed brands; underperformance, redistribution of shelf space, or aggressive competitor pricing can erode market share and royalties.
  • Regulatory risk: changes to cosmetics, fragrance ingredient regulations, cross-border trade/tariff policies or labeling rules in the EU, U.S. or China could require reformulation, relabeling or limit market access, increasing costs and time-to-market.
Metric Illustrative Value / Recent Indicator
Estimated EUR/USD sensitivity (impact on EBIT) ~€10-15m per 5% adverse EUR appreciation (management sensitivity range)
Q1 2025 U.S. sales impact from Dunhill discontinuation Revenue shortfall ~€10-12m vs. prior-year quarter (reported regional trend)
Finished goods inventories Elevated levels; inventory value ~€180-220m (working-capital pressure; ~4-6 months of sales equivalent)
Share of sales in USD-denominated markets ~20-30% of total revenue (significant translation exposure)
Gross margin movement (recent trend) Compression of ~100-200 basis points in recent quarters due to mix, freight and FX
  • Operational levers and mitigants: pricing, cost-of-goods sold optimization, hedging programs and portfolio mix shifts are the primary tools management uses to offset these risks; however, hedging can reduce but not eliminate translation effects and licensing gaps create immediate top-line holes that take quarters to refill.
  • What to watch in quarterly updates: currency sensitivity tables, regional revenue bridges (particularly North America), inventory days and write-downs, new/renewed licensing announcements, and any regulatory compliance costs or product recalls.
Exploring Interparfums SA Investor Profile: Who's Buying and Why?

Interparfums SA (ITP.PA) - Growth Opportunities

Interparfums SA (ITP.PA) is positioned to leverage several concrete growth drivers that should matter to investors assessing medium- to long-term upside. Key strategic pillars-long-term licensing visibility, targeted acquisitions, premium brand expansion, an active innovation pipeline, distribution partnerships and stepped-up A&P-combine to support both top-line expansion and margin resilience.
  • Coach license renewal through June 30, 2031 provides multi-year revenue visibility and cash flow predictability for one of the group's largest mass‑premium franchises.
  • The 2026 acquisitions of Off‑White and Annick Goutal, plus the launch of the proprietary Solférino collection, broaden exposure to higher-margin, luxury and designer segments.
  • Increased allocation to advertising & promotion (A&P) and coordinated new-product launches are intended to drive brand awareness and retail sell‑through across markets.
  • Strategic partnerships with global distributors and key retail chains enable faster market entry and scale, particularly in APAC and the Americas.
  • A focused innovation pipeline (new SKUs, premium flankers, niche launches) supports sustained SKU-level growth and recurring consumer engagement.
Metric FY2021 FY2022 FY2023 3‑yr CAGR
Revenue (€m) 854 1,019 1,153 16.6%
EBITDA margin 16.0% 18.0% 19.0% -
Net income (€m) 68 85 95 19.3%
A&P spend (% of sales) 6.0% 6.5% 7.0% -
Free cash flow (€m) 72 88 102 20.3%
Financial and operational implications for investors:
  • Revenue stability: The Coach license through 2031 reduces short-term renewal risk for a major revenue stream and supports modeling of recurring cash flows.
  • Margin upside: Premiumization from Off‑White and Annick Goutal plus higher A&P efficiency could drive incremental gross and EBITDA margin expansion, supported by historical margin improvement (FY2021→FY2023).
  • Capital allocation: Targeted M&A (2026 purchases) and a steady free cash flow profile support continued buybacks/dividend capacity while funding brand investment.
  • Geographic diversification: Distributor partnerships accelerate penetration in high-growth markets-particularly APAC where premium fragrance growth has outpaced global averages.
  • Execution risk: Benefits depend on successful integration of acquisitions, SKU productivity from Solférino, and A&P-driven conversion rather than just awareness.
For investors seeking context on Interparfums' broader corporate profile, see: Interparfums SA: History, Ownership, Mission, How It Works & Makes Money

DCF model

Interparfums SA (ITP.PA) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.